APTAMIR Trademark

Trademark Overview

On Tuesday, March 26, 2019, a trademark application was filed for APTAMIR with the United States Patent and Trademark Office. The USPTO has given the APTAMIR trademark a serial number of 88356988. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 8, 2023. This trademark is owned by AptamiR Therapeutics, Inc. The APTAMIR trademark is filed in the Pharmaceutical Products category with the following description:

Medicinal and biological preparations for pharmaceutical, clinical or medical treatment, namely, preparations for the modulation of gene and protein expression working at DNA transcription, RNA translation and/or degradation processes related thereto for the treatment of cardiovascular diseases, metabolic diseases, overweight, obesity, diabetes mellitus, dyslipidemia, liver steatosis (fatty liver disease), steatohepatitis, non-alcoholic fatty liver disease, atherosclerosis, and chronic visceral inflammation
aptamir

General Information

Serial Number88356988
Word MarkAPTAMIR
Filing DateTuesday, March 26, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 8, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 11, 2020

Trademark Statements

Description of MarkThe mark consists of the word "APTAMIR" with the first letter "A" in black, the letters "PTA" and "I" in blue, the letter "M" in blue and black, with a blue triangle above, but touching, the letter "M", and the letter "R" in black. The color white represents background and is not a feature of the mark.
Goods and ServicesMedicinal and biological preparations for pharmaceutical, clinical or medical treatment, namely, preparations for the modulation of gene and protein expression working at DNA transcription, RNA translation and/or degradation processes related thereto for the treatment of cardiovascular diseases, metabolic diseases, overweight, obesity, diabetes mellitus, dyslipidemia, liver steatosis (fatty liver disease), steatohepatitis, non-alcoholic fatty liver disease, atherosclerosis, and chronic visceral inflammation
Indication of Colors claimedThe color(s) black and blue is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 11, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAptamiR Therapeutics, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNaples, FL 34119
Party NameAptamiR Therapeutics, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNap, FL 34119

Trademark Events

Event DateEvent Description
Monday, May 8, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 8, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, October 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 12, 2022SOU EXTENSION 5 GRANTED
Tuesday, October 4, 2022SOU EXTENSION 5 FILED
Wednesday, October 12, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 4, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, April 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 1, 2022SOU EXTENSION 4 GRANTED
Friday, April 1, 2022SOU EXTENSION 4 FILED
Friday, April 1, 2022SOU TEAS EXTENSION RECEIVED
Saturday, October 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 30, 2021SOU EXTENSION 3 GRANTED
Thursday, September 30, 2021SOU EXTENSION 3 FILED
Thursday, September 30, 2021SOU TEAS EXTENSION RECEIVED
Friday, April 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 7, 2021SOU EXTENSION 2 GRANTED
Wednesday, April 7, 2021SOU EXTENSION 2 FILED
Wednesday, April 7, 2021SOU TEAS EXTENSION RECEIVED
Monday, April 5, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 5, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, April 5, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 5, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 5, 2020SOU EXTENSION 1 GRANTED
Monday, October 5, 2020SOU EXTENSION 1 FILED
Monday, October 5, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, April 7, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 11, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 11, 2020PUBLISHED FOR OPPOSITION
Wednesday, January 22, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 6, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 6, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 6, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 6, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 13, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 13, 2019NON-FINAL ACTION E-MAILED
Thursday, June 13, 2019NON-FINAL ACTION WRITTEN
Thursday, June 6, 2019ASSIGNED TO EXAMINER
Friday, April 12, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, April 11, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 29, 2019NEW APPLICATION ENTERED

Related Keywords

aptamir liver diseases fatty treatment disease preparations mellitus diabetes obesity metabolic